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We report here that E7 oncoprotein of human papillomavirus type 16 (HPV-16) forms a complex in vivo and in vitro with
actin, one of the components of the cellular cytoskeleton. The in vivo interaction was detected by immunofluorescent staining
and confocal microscopic examination of normal human oral keratinocytes (NHOK) and CV-1 cells after transient expression
of E7 employing the vaccinia virus–T7 RNA polymerase system and by coimmunoprecipitation from an immortalized,
nontumorigenic cell line obtained after transfecting NHOK with the cloned HPV-16 DNA genome. The in vitro interaction was
detected by cosedimentation of bacterially expressed E7 phosphorylated with rabbit reticulocyte lysate or purified casein
kinase II (CKII) prior to incubation with F-actin. This interaction was inhibited if E7 phosphorylation by the rabbit reticulocyte
lysate was prevented with heparin, a CKII inhibitor, or if the amino acids Ser-31 and Ser-32 in E7, which are phosphorylated
by CKII, were replaced with amino acids that cannot be phosphorylated. Interestingly, a decrease in the amount of
polymerized actin occurred in cells expressing E7. © 2000 Academic Press
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One of the hallmarks of malignant transformation is
the alteration of the cellular cytoskeleton, resulting in
decreased adhesion and modified adhesion-dependent
responses (Ben-Ze’ev, 1997; Fey and Penman, 1985; Jan-
mey and Chaponnier, 1995). These alterations involve
structural components of the cytoskeleton or proteins
that interact with this structure at different stages of the
cell cycle (Janmey and Chaponnier, 1995). The major
transforming proteins encoded by the “high-risk” human
papillomaviruses (HPVs), E6 and E7 (Baker et al., 1987;
Munger and Phelps, 1993), bind and inactivate the tumor
suppressor p53 and pRb proteins, respectively, causing
a disruption in cell cycle control (zur Hausen and de
Villiers, 1994). These oncoproteins also interact with sev-
eral other cellular proteins, e.g., cyclin A, AP-1, E2F1,
p21WAF1/CIP1, and p27kip1 (Los Alamos National laboratory
Web site, 1997), which may, in part, be responsible for the
oncogenicity of these viruses (zur Hausen and de
Villiers, 1994).
Interaction between the cytoskeleton and viral pro-
teins has been implicated in the replication and matura-
tion of several human viral pathogens, including vaccinia
virus, human immunodeficiency type 1 virus, measles
virus, and human respiratory syncytial virus (Bohn et al.,
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3721986; Burke et al., 1998; Cudmore et al., 1995; Rey et al.,
1996). Modifications of the cytoskeleton as a result of
viral protein expression have been associated with on-
cogenic transformation by Epstein–Barr virus, Rous sar-
coma virus, and papillomaviruses (Felice et al., 1990;
Martin and Sugden, 1991; McCormack et al., 1997; Tong
and Howley, 1997; Tong et al., 1997). By analyzing the
intracellular distribution of HPV-16 E7 during transient
expression of the viral oncogene, we found that a fraction
of this protein colocalized with F-actin. Similar analysis of
a human oral keratinocytes immortalized with cloned
HPV-16 genome also showed an interaction between E7
and actin. We also demonstrated this association in vitro
by cosedimentation of F-actin and E7. Interestingly, the in
vitro interaction was abolished when the CKII activity,
which is involved in E7 phosphorylation (Firzlaff et al.,
1989), was inhibited by heparin treatment. Furthermore, if
the E7 amino acids that are phosphorylated by CKII were
replaced with amino acids that cannot be phosphory-
lated, the cosedimentation of E7 and F-actin was also
abolished. Interestingly, a decrease in the amount of
F-actin was detected in cells expressing the HPV-16 E7
protein.
RESULTS AND DISCUSSION
Intracellular distribution of E7The intracellular distribution of E7 was analyzed after
transient expression of this protein in primary normal
stainin
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virus–T7 RNA polymerase system. Cells infected with a
recombinant vaccinia virus encoding T7 RNA polymer-
ase (vTF7-3) were transfected with a vector encoding
HPV-16 E7 under the control of the T7 polymerase pro-
moter (pGE7) and processed for indirect immunofluores-
cence 3 h later. A low multiplicity of infection (m.o.i.) (5
PFU/cell) and short time postinfection (less than 4 h)
were employed in our experiments to minimize the cyto-
pathic effects (CPE) associated with vaccinia replication.
As previously reported, vaccinia caused CPE at early
times postinfection only when a high m.o.i. (.150 PFU/
cell) was employed (Bablanian et al., 1978; Bablanian,
1975). NHOK were stained using a murine monoclonal
antibody against E7 (MAbE7) as primary antibody and
FIG. 1. Intracellular E7 protein distribution. NHOK (A–C) or CV-1 cells
H), pGE7 (B–E, I, and J) or pGNP (F) were fixed 3 h posttransfection an
(I and J). E7 was detected using a murine monoclonal antibody and flu
NP was detected using a pool of two murine moclonal antibodies an
detected using a murine monoclonal antibody and fluorescein-conjugat
was costained with Texas red-conjugated phalloidin (I) after E7 immuno
(F–H) 3200 magnification; bars in I–K represent 10 mm.fluorescein-conjugated goat anti-mouse immunoglobulin
as secondary antibody. There was no staining in controlcells infected with vTF7-3 and transfected with empty
vector (pGem4Z) (Fig. 1A). In contrast, approximately 5%
of cells transfected with pGE7 showed a strong nuclear
signal and a weaker cytoplasmic signal (Figs. 1B and
1C). The remaining cells (;95%) were unstained and
similar to the control. We used CV-1 cells for the remain-
ing experiments because the transfection rates in CV-1
were higher than in NHOK. The transfection rate in CV-1
cells was close to 15%. These cells showed a distribution
of E7 similar to that observed in pGE7 transfected NHOK
(Figs. 1D and 1E). Furthermore, CV-1 cells infected with
vTF7-3 and transfected with the empty vector pGem4Z
were not stained by MabE7 (data not shown). Examina-
tion of the E7 distribution in CV-1 cells revealed a fiber-
like staining pattern within the cytoplasm (Fig. 1E, arrow).
fected with vTF7-3 (A–F and H–J) and transfected with pGem4Z (A and
essed for indirect immunofluorescence (A–H) or confocal microscopy
n-conjugated goat anti-mouse immunoglobulins (A–E and J). Influenza
scein-conjugated goat anti-mouse immunoglobulins (F). p16INK4a was
t anti-mouse immunoglobulins (G, H). For actin detection, the specimen
g. (K) The superimposed images of I and J. (A–E) 31000 magnification;(D–J) in
d proc
orescei
d fluore
ed goaSimilar results were obtained employing another murine
monoclonal antibody against E7 (TVG710Y) (data not
374 REY ET AL.shown). In order to rule out nuclear leakage due to CPE
caused by vaccinia virus, we tested under similar con-
ditions the distribution pattern of the influenza virus nu-
cleoprotein (NP), which localizes into the nucleus (Davey
et al., 1985). When NP (56 kDa) was expressed using the
vaccinia/T7 polymerase system, it was detected in the
nucleus as previously reported (Fig. 1F). In addition we
studied the intracellular distribution of an endogenous
cellular protein, the tumor suppressor p16INK4a (16 kDa)
(Serrano, 1997), in vaccinia-infected CV-1 cells. We did
not find any difference in the distribution of this protein
when compared to mock-infected CV-1 cells (Figs. 1G
and 1H). Although high-risk HPVs E7 protein is predom-
inantly nuclear, several reports have indicated that it can
also be detected in the cytoplasm of eukaryotic cells,
albeit at a much lower level than in the nuclei (Bernard et
al., 1987; Kanda et al., 1991). These authors found that a
fraction of E7 could be detected in the cytoplasm regard-
less of different levels of E7 expression or the use of
different cell lines. Since none of these investigators
employed vaccinia virus in their expression systems, it is
very unlikely that the E7 protein they detected in the
cytoplasm resulted from nuclear leakage. Furthermore,
indirect immunofluorescence revealed E7 to be associ-
ated with fiber-like structures in the cytoplasm of COS-1
cells (Kanda et al., 1991).
CV-1 cells infected with vTF7-3 and transfected with
pGE7 were costained with MAbE7 and fluorescein-con-
jugated goat anti-mouse immunoglobulin followed by
Texas red-conjugated phalloidin and analyzed by confo-
cal microscopy to reveal F-actin and E7 distribution,
respectively (Figs. 1I and 1J). Many prominent microfila-
ments running through the cytoplasm of CV-1 as well as
several short microfilaments and speckled staining re-
vealed the F-actin distribution pattern in the cytoplasm of
these cells (Fig. 1I). The longest microfilaments were
located mainly near the cell periphery, with some of them
making contact between two neighboring cells that
showed a similar F-actin pattern (Fig. 1I). In CV-1 cells
expressing E7, immunostaining and confocal micro-
scopic observations revealed E7 localization, which was
very similar to that described in NHOK cells (Fig. 1J).
Although the strongest E7 signal was detected in the
nucleus, several discrete fibers at the cell periphery also
reacted with the anti-E7 antibody. When both images
were superimposed to compare the distribution of E7
and F-actin, they revealed that a fraction of E7 colocal-
ized with peripheral microfilaments (Fig. 1K). A diffuse
signal of E7 apparently not associated with F-actin was
also visible in this superimposed image. Aggregates in
the cytosol, which were stained by Texas red-conjugated
phalloidin, also reacted with the anti-E7 antibody and
they colocalized in the superimposed image. The origin
of these structures is currently unknown. However, there
was no difference in the microfilaments of mock-infected
CV-1 cells compared to CV-1 cells infected with vacciniavirus and transfected with the empty vector under our
experimental conditions (data not shown).
No bleed-over was observed between the signals from
fluorescein and Texas red stains between filter settings.
This phenomenon was demonstrated by two cells that
showed only F-actin and were in close contact with the
cell (the cell in the center of the figure) showing both E7
and F-actin, as well as by the lack of signal in the red
channel from the strong E7 nuclear staining (compare
Figs. 1I and 1J).
Similar results were obtained employing a different
murine monoclonal antibody to E7(TVG710Y) (data not
shown). The colocalization of transiently expressed E7
and F-actin was observed as early as 2 h posttransfec-
tion (data not shown). This observation suggested that
the detected colocalization was not an artifact caused by
overexpression of E7, since the level of E7 present at that
time was considerably lower than that at later times.
In vivo interaction of E7 and actin
The interaction of E7 with cellular microfilaments
noted above could have resulted from the relatively high
level of E7 expression attained with the vaccinia expres-
sion system. These could cause a nonspecific interac-
tion between microfilaments and E7. To address this
question and confirm the in vivo interaction of E7 and
actin in a system where E7 expression was more “phys-
iological,” we utilized a cell line (HOK-16B) that ex-
pressed a low level of E7. HOK-16B cells were estab-
lished by transfection of primary NHOK with the cloned
HPV-16 genome (Park et al., 1991). HOK-16B cells not
only expressed very low levels of E7, e.g., 5.5-fold less
than CaSki cells (Ke et al., 1999), but also had the fol-
lowing advantages: (1) they are immortalized nontumori-
genic cells; (2) their origin from NHOK has been clearly
established; and (3) an appropriate experimental control
(NHOK cells) is readily available. Because we could not
detect the E7 protein by immunofluorescence, very likely
due to its low level (Ke et al., 1999), analysis of the
interaction between E7 and actin was conducted in HOK-
16B cells by radioimmunoprecipitation and Western blot
analysis.
NHOK and HOK-16B cells were pulse-labeled and
enucleated cell lysates immunoprecipitated under non-
denaturing conditions with antibodies against actin or
E7. The immunocomplexes were resolved by SDS–PAGE
and transferred to a membrane. The top portion of the
membrane, between the 30- and the 66-kDa markers,
was excised and incubated with an anti-actin murine
monoclonal antibody and alkaline phosphatase-conju-
gated goat anti-mouse antibody. Signals were detected
employing a chemifluorescent substrate and a phosphor-
imager (Fig. 2A). As indicated under Materials and
Methods, since actin has a very slow turnover, which
made its detection by radiolabeling very inefficient (Chiu
375HPV-16 E7 ONCOPROTEIN INTERACTS WITH F-ACTINand Goldman, 1984; Kreis et al., 1979; Rubinstein et al.,
1976), its visualization was achieved by Western blot. The
lower portion of the same membrane was exposed to a
phosphorimager screen and signals were detected with
a phosphorimager (Fig. 2B), since the small amount of E7
present in HOK-16B did not permit its detection by West-
ern blot. A peptide migrating with an apparent size of
approximately 19 kDa, corresponding to E7, was immu-
noprecipitated from HOK-16B but not from NHOK by
anti-E7. A peptide with the same mobility was also co-
immunoprecipitated by anti-actin antibodies from HOK-
16B cells but not from NHOK. However, actin was not
detected in the immunocomplexes formed in HOK-16B
cells by using a mixture of two different anti-E7 mono-
clonal antibodies under the same experimental condi-
tions. Although we do not currently have an explanation
for this observation, unfavorable steric interactions re-
sulting from the binding of antibodies to E7 may be
responsible for this phenomenon. Similar results were
obtained in CV-1 or NHOK cells using the transient ex-
pression system described above (data not shown).
These data indicate that the association of E7 with
F-actin present in microfilaments was highly specific for
E7 and apparently not dependent upon the intracellular
concentration of E7. Overexposure of the membrane
probed with anti-actin antibodies revealed very faint
bands close to the 46- and 66-kDa marker that did not
comigrate with actin (data not shown). These bands may
FIG. 2. Coimmunoprecipitation of E7 and actin. NHOK or HOK-16B
cells were pulse-labeled and lysed, and the proteins were immunopre-
cipitated under nondenaturing conditions using anti-actin (a-actin) or
anti-E7 (a-E7) murine monoclonal antibodies. The proteins resolved by
SDS–PAGE were transferred to a membrane using standard proce-
dures. The top portion of the membrane was incubated with a-actin as
primary antibody and alkaline phosphatase-conjugated anti-mouse as
secondary antibody for actin detection (A). Signals were detected with
a chemifluorescent substrate and a phosphorimager. The lower portion
of the same membrane was exposed to phosphorimager screens and
signals detected with a phosphorimager (B). The position of protein
molecular weight markers is indicated on the right.correspond to the heavy chain of anti-actin IgM (78 kDa)
and anti-E7 IgG (55 kDa).E7 can form a complex with F-actin in vitro
To further ascertain the E7/F-actin interaction, we em-
ployed an in vitro binding assay (Matsudaira, 1992; Rey
et al., 1996) using bacterially expressed E7 and in vitro
polymerized actin (F-actin). This assay was based on the
fact that proteins with moderate to high binding affinities
(,10 mM kDa) for actin can be detected by cosedimen-
tation since F-actin pellets at high (100,000 g) but not low
(10,000 g) centrifugal forces (Matsudaira, 1992). Bacteri-
ally expressed glutathione S-transferase (GST)–E7 fusion
protein was purified and the GST moiety removed by
enzymatic cleavage with thrombin. The obtained E7 pro-
tein incubated with in vitro polymerized actin was cen-
trifuged and equal volumes of the solubilized pellet and
supernatant were analyzed by Western blot. Signals
were detected as described under Materials and Meth-
ods. Unexpectedly, E7 did not cosediment with F-actin
(data not shown).
This disparity between the in vivo and the in vitro
experimental results could be due to the absence of a
cellular factor(s) in the in vitro assay that is necessary for
the E7 and F-actin interaction. For example, in our in vitro
assay we used highly purified monomeric actin (.99%)
in order to obtain F-actin. Because microfilaments in the
cell are formed by polymerized actin and several other
proteins, such as troponin, myosin, caldesmon, fimbrin,
and adducin (Kreis and Vale, 1993), the lack of any of
these proteins or other cobinding factor(s) could have
affected the ability of E7 to interact with F-actin. Also,
posttranslational modifications of E7, which may occur in
eukaryotic cells, could be absent in the bacterially ex-
pressed protein, affecting its ability to interact with other
proteins. To address these possibilities, we conducted
the in vitro binding assay in the presence of 10 ml of
rabbit reticulocyte lysate (RL), which contains a variety of
posttranslational processing activities, as well as multi-
ple cellular factors (Jackson and Hunt, 1983). As positive
and negative controls, we included purified bacterially
expressed HIV-1 Gag protein, which interacts with
F-actin (Rey et al., 1996), and GST, which does not. Under
these experimental conditions, significant cosedimenta-
tion of E7 occurred with F-actin (Fig. 3). Quantitation of
the obtained signals indicated that in the absence of
F-actin, 10% of GST, 24% of Gag and 10% of E7 were
present in the pellet. The inclusion of F-actin increased
the amount of GST in the pellet by only 8%. The amount
of Gag, the positive control cosedimenting with F-actin,
was 34% higher than in the absence of F-actin and E7
showed a net increase of 28%. We cannot rule out the
possibility that some of the E7 protein that cosedimented
with F-actin resulted from trapping. Nevertheless, the
results obtained with the negative controls GST and
bovine serum albumin (data not shown) indicated that a
significant amount of E7 cosedimented with F-actin.
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phosphorylation of E7
Previous reports have indicated that E7 can be phos-
phorylated by CKII (Barbosa et al., 1990; Firzlaff et al.,
1989), a ubiquitous active kinase in the cytosol and
nucleus (Edelman et al., 1987; Filhol et al., 1990; Hatha-
way and Traugh, 1982; Kandror et al., 1989; Singh and
Huang, 1985) that can be activated by different growth
factors (Meisner and Czech, 1991). To determine whether
E7 phosphorylation is mediated by CKII in the rabbit RL,
heparin was included in the assay. Heparin is a potent
inhibitor of CKII, which has no effect on other kinases
such as casein kinase I, type I and II cAMP-dependent
protein kinases, protease-activated kinase I, and the
hemin-controlled repressor (Feige et al., 1980; Hathaway
et al., 1980; Hathaway and Traugh, 1982; Maenpaa, 1977).
After incubation with or without heparin, E7 was immu-
noprecipitated with the MAbE7, samples were analyzed
by SDS–PAGE, and signals were detected with a phos-
FIG. 3. E7/F-actin in vitro interaction. Bacterially expressed GST,
HIV-1 Gag, and E7 were incubated with (1) or without (2) in vitro
polymerized actin (F-actin) and centrifuged in a Beckman airfuge for 20
min at 100,000 g. The supernatant (S) and pellet (P) were analyzed by
SDS–PAGE and Western blotting. GST (A), Gag (B), and E7 (C) were
detected employing primary antibodies against these proteins and
secondary alkaline phosphatase-conjugated antibodies. Signals were
quantified using a phosphorimager and expressed (D) as a percentage
of the total protein (100% equals S 1 P).phorimager. As shown in Fig. 4, the inclusion of heparin
prevented the phosphorylation of E7. If phosphorylationof E7 by CKII was necessary for the interaction between
F-actin and this protein, prevention of E7 phosphorylation
should abrogate this interaction. Indeed, when heparin
was included in the in vitro binding assay in the pres-
ence of RL before the addition of E7, E7 did not cosedi-
ment with F-actin (Fig. 5). Moreover, the distribution of E7
FIG. 4. In vitro phosphorylation of E7 protein. Bacterially expressed
E7 was incubated with rabbit reticulocyte lysate (RL) and [g-32P]ATP in
he presence (1) or in the absence (2) of the CKII inhibitor heparin.
amples, immunoprecipitated using a murine monoclonal antibody
gainst E7, were resolved by SDS–PAGE. Signals were detected using
phosphorimager. Hep, heparin. The position of protein molecular
eight markers is indicated on the right.
FIG. 5. Effect of CKII inhibition on E7/F-actin in vitro interaction.
Bacterially expressed E7 was incubated with (1) or without (2) the CKII
inhibitor heparin and in vitro polymerized actin (F-actin). The superna-
tant (S) and pellet (P), obtained after centrifugation of samples in a
Beckman airfuge for 20 min at 100,000 g, were analyzed by SDS–PAGE
and Western blotting. E7 (A) was detected employing a primary anti-
body against E7 and secondary alkaline phosphatase conjugated an-
tibodies. Signals were quantified using a phosphorimager and ex-
pressed (B) as a percentage of the total protein (100% equals S 1 P).
Hep, heparin.
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377HPV-16 E7 ONCOPROTEIN INTERACTS WITH F-ACTINunder these conditions was the same as that of E7
incubated without F-actin. When heparin was added 1 h
after E7, it did not affect the ability of this protein to
interact with F-actin (data not shown). These results
suggest that E7 phosphorylation by CKII is required for
its interaction with F-actin.
To further demonstrate that phosphorylation was
needed for E7 to associate with F-actin, purified CKII was
used to phosphorylate bacterially expressed E7. In addi-
tion, the 31/32 E7 mutant protein in which the amino
acids Ser-31 and Ser-32, which are phosphorylated by
CKII, were mutated to amino acids Ala and Ala (that
cannot be phosphorylated), respectively, was con-
structed and tested for its ability to interact with F-actin.
As shown in Fig. 6A, E7 phosphorylated by purified CKII
was able to cosediment with F-actin in the absence of
RL. Under these conditions the binding ability of E7 was
FIG. 6. E7 CKII phosphorylation-deficient mutant and F-actin in vitro
nteraction. Bacterially expressed wt E7 (A) or 31/32 mutant E7 (B)
roteins were incubated with purified CKII and then with in vitro
olymerized actin (F-actin). The supernatant (S) and pellet (P) obtained
fter centrifugation of the samples in a Beckman airfuge for 20 min at
00,000 g, were analyzed by SDS–PAGE and Western blotting. E7 was
etected employing a primary antibody against E7 and secondary
lkaline phosphatase-conjugated antibodies. Signals were quantified
sing a phosphorimager and expressed as a percentage of the total
rotein (100% equals to S 1 P). Results were the mean of three
ndependent experiments. Bars represent the standard deviation. RL,
abbit reticulocyte lysate.decreased when compared to the previous results (see
Figs. 4 and 5), raising the possibility that other factorspresent in the RL increased its binding efficiency. There
was no significant difference in E7 phosphorylation by
purified CKII or RL (data not shown).
The 31/32 E7 mutant protein showed, on average, a 5%
net increase in its ability to pellet in the absence of
F-actin when compared to the E7 wild-type (wt) protein
under the same conditions (Fig. 6B). When F-actin was
included in the in vitro binding assay and the E7 mutant
protein treated with CKII, the amount of mutant E7 co-
sedimenting with F-actin was the same as in the ab-
sence of F-actin, indicating that the interaction between
these two proteins was disrupted (Fig. 6B). The same
results were obtained when RL was included in the
assay with the mutant E7 protein and F-actin. Similar
results were obtained with another E7 mutant protein
where the 31/32 Ser/Ser residues were mutated to 31/32
Arg/Pro (data not shown).
F-actin distribution is affected in cells expressing E7
Our results indicated that the E7 protein was able to
interact in vitro and in vivo with F-actin, a phenomenon
that could affect the actin cytoskeleton. To address this
possibility, the microfilaments of NHOK and HOK-16B
cells were labeled with Texas red-conjugated phalloidin
and analyzed by confocal microscopy (Fig. 7). As evident
from representative images, NHOK cells had an elabo-
rate cytosolic network of F-actin fibers (Fig. 7A) that was
mostly absent in the HOK-16B cells (Fig. 7B). Although
both cell types showed microspikes, these structures
were more noticeable, uniform, and evenly distributed in
NHOK cells. Analysis of F-actin distribution in another
NHOK-derived cell line that expressed only the E7 pro-
tein (HOK-16E7) (Fig. 7C) showed the same profile as in
HOK-16B, suggesting that the observed decrease in
F-actin was linked to E7 expression. The difference in the
actin network of NHOK with that of HOK-16B and HOK-
16E7 was not caused by cell clustering or piling up
because these artifacts were not observed in serial con-
focal images of NHOK cells (data not shown).
Under normal physiological conditions there is equi-
librium between nonpolymerized, monomeric actin and
polymerized actin in the cellular cytosol, with approxi-
mately half of the actin present in the nonpolymerized
form (Bershadsky and Vasiliev, 1988). Since phalloidin
binds only to F-actin and not to monomeric actin, the
difference in immunofluorescence intensity detected be-
tween NHOK and the other two cell lines that express E7
may only reflect a shift in the distribution of actin. To
determine whether there was a net difference in actin
content between NHOK, HOK-16B, and HOK-16E7, cell
lysates were analyzed by Western blot using an anti-
actin monoclonal antibody. No significant difference was
detected in the amount of actin present in HOK-16B or
HOK-16E7 cells compared to NHOK cells (Fig. 8), sug-
gesting that the decrease in F-actin detected in E7 ex-
378 REY ET AL.pressing cells reflects a defect in actin polymerization.
The observed difference in actin distribution might be a
secondary phenomenon due to immortalization in both
E7 expressing cell lines and requires further analysis.
The data presented here reveal a novel function of
high-risk HPV in NHOK and CV-1 cells, e.g., the associ-
ation of the HPV-16 E7 oncoprotein with actin, a compo-
nent of the cytoskeleton. This observation is based on
results obtained from several independent in vivo and in
vitro experimental approaches. Interestingly, we also
FIG. 7. Microfilament organization in cells expressing E7. NHOK (A),
HOK-16B (B), or HOK-16E7 cells (C) were fixed and F-actin was de-
tected by staining with Texas red-conjugated phalloidin and confocal
microscopy. Bars represent 10 mm.noted that the actin cytoskeleton was significantly dis-
rupted in cells expressing E7.F-actin is part of cellular structures, e.g., microfila-
ments and the cell cortex, which interact with several
structural and regulatory components (Schliwa, 1986).
These interactions are critical for cellular morphology,
cytoskeletal organization, motility, adhesion, and signal
transduction (Assoian and Zhu, 1997). Therefore, F-actin
modifications will not only affect cytoskeletal organiza-
tion but can also disrupt several cellular functions (Ben-
Ze’ev, 1997; Janmey and Chaponnier, 1995).
Modifications of the cytoskeleton resulting from viral
protein expression have been implicated in the onco-
genic transformation associated with several other vi-
ruses (Felice et al., 1990; Martin and Sugden, 1991; Mc-
Cormack et al., 1997; Tong and Howley, 1997; Tong et al.,
1997). In the case of bovine papillomavirus type 1 (BPV-
1), evidence has been presented that the E6 oncoprotein
interacts with paxillin, a component of the focal adhe-
sion. This interaction appears to be involved in the ability
of BPV-1 E6 protein to disrupt the cytoskeleton as part of
the oncogenic potential of this virus (Tong and Howley,
1997; Tong et al., 1997). Other viruses such as measles
virus, rabies virus, human respiratory syncytial virus, and
HIV-1 also encode proteins that interact with the cy-
toskeleton; however, the role of these interactions in viral
replication or their effect on their respective hosts re-
mains speculative (Bohn et al., 1986; Burke et al., 1998;
Rey et al., 1996; Sagara et al., 1995).
FIG. 8. Actin steady state in cells expressing E7. Total protein extracts
from NHOK, HOK-16B, and HOK-16E7 were electrophoresed on SDS–10%
PAGE and transferred to membranes. The membrane was sequentially
decorated with murine monoclonal antibodies against actin and then
b-tubulin and alkaline phosphatase-conjugated second antibody plus a
chemifluorescent substrate (A). Detection and quantitation (B) were per-
formed with a phosphorimager. The obtained actin values were normal-
ized by comparison with the b-tubulin content. A.U., arbitrary units.
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379HPV-16 E7 ONCOPROTEIN INTERACTS WITH F-ACTINIn conclusion, HPV-16 may not only inactivate the tu-
mor suppressor proteins p53 and pRB with its E6 and E7
oncoproteins, respectively, but could also alter other cel-
lular functions through E7 interaction with the cytoskel-
eton or associated proteins. This possibility is being
investigated in our laboratory.
MATERIALS AND METHODS
Cells and viruses
Primary NHOK, HOK-16B cells, and NHOK expressing
only HPV-16 E7 were cultured as described previously
(Liu et al., 1997; Park et al., 1991) in keratinocyte growth
edium supplemented with reagents supplied in the
ullet kit (Clonetics Corp., San Diego, CA). African green
onkey kidney (CV-1) cells were obtained from the
merican Type Culture Collection (ATCC) and main-
ained as recommended by the ATCC. Vaccinia virus
vTF7-3) was propagated and purified as previously de-
cribed (Fuerst et al., 1987).
lasmid constructions
The plasmid pGE7, encoding the wt HPV-16 E7 protein
nder the control of the T7 RNA polymerase promoter,
as constructed by subcloning a cDNA fragment con-
aining the complete E7 ORF (nucleotides 505 to 1176)
solated from pE7Mo (Edmonds and Vousden, 1989) into
Gem4Z (Promega Corp., Madison, WI). The construct
enerated was confirmed by DNA sequence analyses.
he plasmid pGNP, encoding the influenza virus (A/PR/
/34 strain) nucleoprotein under the control of the T7
romoter, was a gift from D. Nayak (Biswas and Nayak,
996).
ransient E7 protein expression
WT E7 protein expression was induced in cells using
he vaccinia virus–T7 RNA polymerase system (Fuerst et
al., 1987). Cells were incubated for 1 h at 37°C with the
recombinant vaccinia virus vTF7-3, encoding the T7 RNA
polymerase, at a multiplicity of infection of 5 PFU/cell,
and then transfected with pGE7 employing Lipo-
fectAMINE PLUS (Gibco BRL, Gaithersburg, MD) follow-
ing the manufacturer’s suggested conditions. Unless in-
dicated otherwise, the cultures were incubated for an
additional 3 h at 37°C before being processed.
Immunofluorescence and confocal microscopy
Cells cultured on Lab-Tek chamber slides (Nalge Nunc
International, Naperville, IL) were fixed for 15 min at 25°C
in 10% buffered formalin phosphate and permeabilized
with 0.4% Triton X-100 in phosphate-buffered saline for 5
min at 25°C (Lane and Harlow, 1988). Immunostaining
was performed as previously described (Rey and Nayak,
1992). F-actin was stained with Texas red-conjugated
phalloidin (Molecular Probes, Eugene, OR) as recom-mended by the manufacturer. Imaging was performed
using an Olympus BH-2 RFCA (immunofluorescence) or
a C. Zeiss LSM 310 confocal microscope.
Radiolabeling, immunoprecipitation, and Western blot
analyses
Coimmunoprecipitation experiments were performed
with cultured NHOK or HOK-16B monolayer cells (2–3 3
106 cells) incubated for 30 min in cysteine-free minimal
essential medium with 5% dialyzed fetal bovine serum
and then pulse-labeled with 50 mCi/ml of [35S]cysteine
(ICN Biomedicals, Inc., Irvine, CA) for 2 h. After being
labeled, the cells were lysed by incubation for 30 min at
4°C in 1 ml of 1XRIPA minus sodium dodecyl sulfate
(SDS) [50 mM Tris–HCl, pH 7.6; 150 mM NaCl; 1% Triton
X-100; 0.5% sodium deoxycholate; and a protease inhib-
itor cocktail (Boehringer Mannheim, GmbH, Germany)].
The cell lysates were centrifuged at 8000 g for 10 min at
4°C. Pellets containing debris, unsolubilized proteins,
and nuclei were discarded. Proteins were immunopre-
cipitated from the supernatant at 4°C under nondenatur-
ing conditions employing a murine monoclonal anti-actin
antibody (400 ng IgM) and a mixture of two murine
monoclonal anti-E7 antibodies (300 ng IgG). The immune
complexes, collected with a mixture of Protein A–Sepha-
rose (Pharmacia Biotech AB, Uppsala, Sweden) and Pro-
tein G Plus–agarose (Calbiochem–Novabiochem Corp.,
La Jolla, CA), were washed three times with ice-cold
washing solution (50 mM Tris–HCl, pH 7.6; 500 mM NaCl;
1% Triton X-100; 0.5% sodium deoxycholate; 1% BSA; and
protease inhibitor cocktail) and once with 1XRIPA minus
SDS. Proteins were extracted for 10 min at 95°C in 23
SDS–sample buffer (13 SDS–sample buffer: 62.5 mM
Tris–HCl, pH 6.8; 2% SDS; 2 mM EDTA; 5% 2-mercapto-
ethanol; 10% glycerol; and 0.001% bromophenol blue),
electrophoretically separated in SDS–12% polyacryl-
amide gels, and transferred to Immuno-Blot PVDF mem-
branes (Bio-Rad Laboratories, Hercules, CA) using stan-
dard procedures. Actin was detected by specific interac-
tion of the transferred proteins in the membrane with an
antibody against actin in place of exposing it to phos-
phorimager screens. This was necessary since actin has
a very slow turnover (Chiu and Goldman, 1984; Kreis et
al., 1979), which made its detection by radiolabeling very
inefficient. Thus, the top portion of the membranes, be-
tween the 30- and the 66-kDa markers, was excised and
incubated wit primary murine monoclonal antibodies us-
ing standard procedures and alkaline phosphatase-con-
jugated anti-mouse secondary antibody. Signals were
detected employing a chemifluorescent substrate (Vistra
Systems, Amersham Life Sciences) and a Storm 840
phosphorimager. The lower portion of the same mem-
brane was exposed to phosphorimager screens and
signals detected with a Storm 840 phosphorimager (Mo-
lecular Dynamics, Sunnyvale, CA).
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purification
The fusion protein plasmid encoding the wt E7 (pGEX-
E7) was constructed by subcloning the blunt-ended NsiI/
NcoI fragment (nucleotides 566 to 864) isolated from
pE7Mo (Edmonds and Vousden, 1989), into pGEX-4T-1
(Amersham Pharmacia Biotech, Inc., Piscataway, NJ) that
had been digested with SmaI and dephosphorylated.
The fusion protein plasmid pGEX-E7-31/32Ala/Ala was
constructed by subcloning the blunt-ended NsiI/NcoI
fragment (nucleotides 566 to 864) isolated from pGE7-
31/32Ala/Ala into pGEX-4T-1 (Amersham Pharmacia Bio-
tech, Inc.) previously digested with SmaI and dephos-
phorylated. The plasmid pGE7-31/32Ala/Ala, where the
31Ser and 32Ser amino acid residues from the E7 wt
protein were mutated to 31Ala and 32Ala, was con-
structed by PCR site-directed mutagenesis (Ausubel,
1987) of pGE7 using the mutagenic primer 59-GAGCAA-
TTAATGACGCCGCAGAGGAGGAGGATGAA-39. All the
constructs generated were confirmed by DNA sequence
analyses. After expression of the glutathione S-trans-
ferase fusion proteins in Escherichia coli, the proteins
were purified and the GST moiety was removed by en-
zymatic cleavage with thrombin following standard pro-
cedures (Ausubel, 1987).
In vitro binding assay
Purified rabbit skeletal muscle actin (Cytoskeleton,
Denver, CO) (4 mg/ml) was polymerized in vitro in a
buffer containing 50 mM KCl, 1 mM MgCl2, 10 mM Tris–
Cl, pH 7.4, 1 mM ATP, and 50 mg/ml phalloidin (Molec-
lar Probes) at room temperature for 2 h (Rey et al.,
996). Mutant or wt fusion proteins (6 mg) were incubated
in vitro with polymerized actin (10 mM final concentration)
in an actin binding buffer (ABB: 75 mM NaCl; 3 mM
MgCl2; 10 mM Tris–HCl, pH 7.4; and 3 mM ATP) at 4°C for
h in a final volume of 150 ml with or without rabbit RL
0 ml/reaction (Promega Corp.). Samples were then cen-
rifuged in a Beckman airfuge for 20 min at 100,000 g.
he supernatant was removed and the pellet resus-
ended in an equivalent volume of ABB. The pellet and
upernatant were solubilized in 43 SDS–sample buffer
nd aliquots were analyzed by Western blot.
n vitro phosphorylation of E7
In vitro phosphorylation of E7 was carried out by in-
ubating 1 mg of purified wt or mutant protein in a
solution containing 75 mM NaCl, 3 mM MgCl2, 10 mM
Tris–HCl (pH 7.4), and 10 mCi [g-32P]ATP (ICN Biomedi-
als, Inc., Irvine, CA) or 0.1 mM ATP and 5 ml of RL at
30°C for 30 min. Alternatively, the RL in the reaction was
replaced by purified CK II (500 units/reaction; New En-
gland Biolabs, Inc., Beverly, MA) and 0.1 mM ATP. Hep-
arin (10 mM final concentration; Sigma, St. Louis, MO) Bas used as an inhibitor of CKII activity (Hathaway and
raugh, 1982).
ntibodies
The following antibodies were used: a murine mono-
lonal antibody against HPV-16 E7 protein (TVG710Y;
anta Cruz Biotechnology, Santa Cruz, CA); a murine
onoclonal antibody specific for p16INK4a (F-12; Santa
Cruz Biotechnology); murine monoclonal antibodies spe-
cific for actin and for b-tubulin (Amersham Pharmacia
iotech); a murine monoclonal antibody against HPV-16
7 (Zymed Laboratories Inc., San Francisco, CA); alkaline
hosphatase-conjugated goat anti-mouse antibodies
Santa Cruz Biotechnology); fluorescein-conjugated goat
nti-mouse antibodies (Organon Teknica Corp., West
hester, PA); and murine monoclonal antibodies against
nfluenza virus NP (H16-L10-4R5 and 46/4, ATCC).
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